These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26379494)

  • 1. Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease.
    Saura CA; Parra-Damas A; Enriquez-Barreto L
    Front Cell Neurosci; 2015; 9():318. PubMed ID: 26379494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Excitability Changes in the Medial Entorhinal Cortex in the 3xTg Mouse Model of Alzheimer's Disease Pathology.
    Chen L; Christenson Wick Z; Vetere LM; Vaughan N; Jurkowski A; Galas A; Diego KS; Philipsberg PA; Soler I; Feng Y; Cai DJ; Shuman T
    J Neurosci; 2023 Nov; 43(44):7441-7454. PubMed ID: 37714705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic characterization of a non-transgenic Aβ
    Jiménez-Herrera R; Contreras A; Djebari S; Mulero-Franco J; Iborra-Lázaro G; Jeremic D; Navarro-López J; Jiménez-Díaz L
    Biol Sex Differ; 2023 Sep; 14(1):59. PubMed ID: 37716988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages.
    Parra-Damas A; Valero J; Chen M; España J; Martín E; Ferrer I; Rodríguez-Alvarez J; Saura CA
    J Neurosci; 2014 Apr; 34(17):5776-87. PubMed ID: 24760838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.
    Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW
    Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.
    Martin Flores N; Podpolny M; McLeod F; Workman I; Crawford K; Ivanov D; Leonenko G; Escott-Price V; Salinas PC
    Elife; 2024 Jan; 12():. PubMed ID: 38285009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
    Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
    J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau.
    McCollum LE; Das SR; Xie L; de Flores R; Wang J; Xie SX; Wisse LEM; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2021; 31():102717. PubMed ID: 34119903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
    Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
    Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.
    Nava-Mesa MO; Jiménez-Díaz L; Yajeya J; Navarro-Lopez JD
    Front Cell Neurosci; 2014; 8():167. PubMed ID: 24987334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer's disease.
    Chakroborty S; Hill ES; Christian DT; Helfrich R; Riley S; Schneider C; Kapecki N; Mustaly-Kalimi S; Seiler FA; Peterson DA; West AR; Vertel BM; Frost WN; Stutzmann GE
    Mol Neurodegener; 2019 Jan; 14(1):7. PubMed ID: 30670054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.